121 related articles for article (PubMed ID: 2359855)
1. [The relationship between the receptor status and the mammographic picture in operable breast cancer].
Ventrella V; Paradiso A; Farchi G; Tommasi S; Schittulli F; Racanelli A; De Lena M
Radiol Med; 1990 May; 79(5):483-8. PubMed ID: 2359855
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
Macías A; Pascual MR; Pérez R; Lage A
Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
[TBL] [Abstract][Full Text] [Related]
4. Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancer.
Paradiso A; Ventrella V; Farchi G; Tommasi S; Mangia A; Barletta A; Schittulli F; Racanelli A; De Lena M
Oncology; 1993; 50(2):104-9. PubMed ID: 8383827
[TBL] [Abstract][Full Text] [Related]
5. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer: reliability of mammographic appearance as a predictor of hormone receptor status.
Ciatto S; Morrone D; Catarzi S; Bonardi R
Radiology; 1992 Mar; 182(3):805-8. PubMed ID: 1311118
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.
Bernoux A; de Cremoux P; Lainé-Bidron C; Martin EC; Asselain B; Magdelénat H
Breast Cancer Res Treat; 1998 Jun; 49(3):219-25. PubMed ID: 9776505
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the content of estrogen and progesterone receptors and the pathological characteristics in human breast cancer.
Nishimura R; Misumi A; Kimura M; Tokunaga T; Akagi M
Jpn J Surg; 1982; 12(3):191-7. PubMed ID: 6290728
[TBL] [Abstract][Full Text] [Related]
9. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB
Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptors and prognosis in operable (stage I and II) breast cancer.
Stewart JF; Rubens RD; Millis RR; King RJ; Hayward JL
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1381-7. PubMed ID: 6315442
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor positive operable breast cancer: does menopausal status impact on HER2 and progesterone receptor status?
Wang N; Wang B; Wang Y; Hu J
Breast; 2011 Dec; 20(6):519-24. PubMed ID: 21700456
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
14. [Correlation with mammography and estrogen receptors in breast neoplasms].
Lorenzetti G; De Rubeis GP
G Ital Oncol; 1990; 10(1-2):41-6. PubMed ID: 2358309
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progesterone receptors as prognostic factors in breast cancer.
Brdar B; Graf D; Padovan R; Nola P; Rudan N; Petrinec Z; Sarcević B; Belicza M
Tumori; 1988 Feb; 74(1):45-52. PubMed ID: 3354064
[TBL] [Abstract][Full Text] [Related]
16. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
[TBL] [Abstract][Full Text] [Related]
17. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.
Ben-David M; Wittliff JL; Fekete M; Kadar T; Biran S; Schally AV
Biomed Pharmacother; 1988; 42(5):327-34. PubMed ID: 3191209
[TBL] [Abstract][Full Text] [Related]
18. Relation between mammographic findings and hormonal receptor content in breast cancer.
Nielsen NS; Poulsen HS
AJR Am J Roentgenol; 1985 Sep; 145(3):501-4. PubMed ID: 2992254
[TBL] [Abstract][Full Text] [Related]
19. [Studies on estrogen and progesterone receptors in human breast cancer by sucrose gradient centrifugation (author's transl)].
Iino Y
Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):971-93. PubMed ID: 488478
[TBL] [Abstract][Full Text] [Related]
20. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
Redkar AA; Kabre SS; Mittra I
Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
